Sr. Director, Medical Affairs, Neurometabolic Team
About The Position
The Senior Director, Medical Affairs, Neurometabolic Team leads U.S. Medical Affairs strategy for ITF Therapeutics' rare neurometabolic disease portfolio. Reporting to the VP, US Medical Affairs & Patient Advocacy, this role is the senior U.S. medical leader for the portfolio and translates global medical strategy into effective U.S. plans and successful launch execution. As a member of the U.S. Medical Affairs leadership team, the Senior Director provides strategic and scientific leadership across product development and commercialization. The role oversees U.S. medical strategy, launch readiness, scientific engagement, field medical effectiveness, medical communications, education, payer engagement, and cross-functional execution. In partnership with the Global Medical Director, the Senior Director represents the U.S. medical perspective and helps ensure global evidence generation and medical activities address U.S. stakeholder needs. The role also builds and develops a high-performing U.S. Medical Affairs neurometabolic team, fostering scientific excellence, collaboration, patient centricity, and innovation.
Requirements
- MD, PharmD, or PhD in a relevant scientific, medical, or healthcare discipline.
- 12 or more years of progressive pharmaceutical or biotechnology experience in Medical Affairs, Clinical Development, or related functions.
- Demonstrated success leading U.S. Medical Affairs organizations and launch readiness activities for rare disease and/or specialty products.
- Experience partnering effectively with Global Medical Affairs teams in a matrixed multinational organization.
- Ability to influence global strategy through U.S. market insights, external stakeholder engagement, and evidence generation planning.
- Strong understanding of evidence generation, publication planning, scientific communications, medical governance, and healthcare decision-making processes.
- Significant experience engaging KOLs, researchers, advocacy organizations, payers, and healthcare systems.
- Demonstrated ability to operate strategically while driving execution.
Nice To Haves
- Experience in neurometabolic disease or lysosomal storage diseases.
- Experience supporting product launches and pre-launch Medical Affairs activities.
- Expertise in neurometabolic disorders, rare diseases, neuroscience, genetics, or related therapeutic areas.
- Experience with insight generation, customer engagement platforms, and CRM systems.
- Demonstrated success managing departmental budgets and resource planning.
- Experience working in a global or matrixed organizational environment.
Responsibilities
- Develop and execute integrated U.S. Medical Affairs strategies and tactical plans across pre-launch, launch, and lifecycle stages.
- Provide senior U.S. medical leadership for target neurometabolic diseases, supporting patient identification, disease and product knowledge, and improved patient outcomes.
- Lead U.S. medical launch planning and execution, including readiness plans for field medical, scientific communications, education, insight generation, congresses, advisory boards, and stakeholder engagement.
- Partner with Commercial, Market Access, Regulatory, Patient Advocacy, Global Medical Affairs, and Clinical Development to coordinate launch execution.
- Identify and mitigate launch risks and respond to emerging opportunities and competitive dynamics.
- Lead U.S. scientific communication and medical education strategies, including scientific exchange, congress activities, educational programs, and content development.
- Align U.S. communication plans with global publication and evidence dissemination strategies; review and approve U.S. medical materials.
- Drive insight generation and turn stakeholder insights into recommendations for development, launch, and lifecycle strategies.
- Provide U.S. strategic input into evidence generation priorities, study concepts, real-world evidence initiatives, publication planning, and data dissemination.
- Monitor scientific, clinical, regulatory, policy, and competitive developments.
- Build and maintain relationships with KOLs, investigators, healthcare professionals, patient advocacy organizations, professional societies, payers, and other stakeholders.
- Lead advisory boards and expert consultations, and represent ITF Therapeutics at scientific, advocacy, and industry forums.
- Partner with Market Access and HEOR on evidence demonstrating clinical, economic, and patient-centered value; support payer-facing medical engagements and patient access objectives.
- Serve as a strategic partner to Commercial, Clinical Development, Regulatory Affairs, Market Access, Safety, Patient Advocacy, and Global Medical Affairs.
- Act as the primary U.S. partner to the Global Neurometabolic Medical Director, contributing U.S. insights to disease and product strategy, lifecycle planning, evidence generation, publication priorities, and scientific platform development.
- Align U.S. and global stakeholders while maintaining scientific integrity and patient focus.
- Build, lead, coach, and develop a high-performing U.S. Medical Affairs neurometabolic team.
- Set team priorities and performance expectations and establish development plans that support organizational growth and succession planning.
- Promote a patient-centered culture that balances scientific rigor with meaningful healthcare impact.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
What This Job Offers
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree
